Why Okta Stock Is Rising Today
Shares of Okta (NASDAQ: OKTA) were climbing today after health officials in the U.S. recommended that use of the Johnson & Johnson coronavirus vaccine be paused until more information about potential blood clots can be assessed.
The tech stock was up 6% as of 1:57 p.m. EDT.
Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention recommended that the Johnson & Johnson vaccine not be used right now "out of an abundance of caution." The agencies are reviewing "six reported U.S. cases of a rare and severe type of blood clot" that occurred in those individuals after taking the vaccine. To date, 6.8 million doses of the Johnson & Johnson vaccine have been administered.
Source Fool.com
